Healthcare >> CEO Interviews >> December 14, 1998
DAVID J. MCLACHLAN joined Genzyme Corporation in 1989 and is the
company's Senior Vice President, Finance, and Chief Financial Officer.
He also serves as Director, Treasurer and Chief Financial Officer of IG
Laboratories, Inc., a majority-owned genetic testing company of Genzyme.
In addition, he is the Chief Financial Officer of Neozyme II
Corporation, founded in 1992 to engage in the research and development
of treatments for cystic fibrosis, and Genzyme Transgenics Corporation,
a majority-owned Genzyme subsidiary engaged in the application of
transgenic technology for the development of recombinant proteins for
therapeutic and diagnostic uses. Prior to joining Genzyme, Mr. McLachlan
was Vice President, Finance of Adams Russell, Inc., a defense
electronics manufacturer, and of Adams-Russell Co., Inc, a cable
television company. He currently serves on the Board of Directors of
HearX, Ltd., a hearing care company. Mr. McLachlan is also a Town
Meeting Representative and a member of the Conservation Committee for
the town of Chelmsford, Massachusetts.
(FAT615)(FU8) Profile
history, products, customers, those kinds of things?
Mr. McLachlan: Genzyme Corporation is a very broad-based
